The Astellas UK affiliate was already suspended for a year in June 2016 after it took doctors to a medical conference in Milan, Italy which included a presentation about benefits of its Xtandi ...

Astellas confirmed today that it will withdraw its EMA filing for avacincaptad pegol as a treatment for eye disorder geographic atrophy (GA), based on feedback from the EU regulator. It is a major ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Discover outperforming stocks and invest smarter with Top Smart Score Stocks Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener Astellas Pharma ...

(RTTNews) - Astellas Pharma Inc. (ALPMY, ALPMY) announced that China's National Medical Products Administration approved VYLOY (zolbetuximab), in combination with fluoropyrimidine- and platinum ...

Medicare has announced 15 new drugs up for price negotiations, set to begin in the next several months with top drugmakers, ...

Here are some before and after pictures of the company's wordmark and logo. Here's a look at how the new wordmark and logo will appear on storefronts. Social media users react to Walmart's logo ...

Walmart is refreshing its logo for the first time in nearly two decades, highlighting its evolution while also serving as a nod to its past, the big-box retailer announced Monday. The word mark on ...

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Zolbetuximab is under clinical development by Astellas Pharma and currently in Pre-Registration for Gastric Cancer. According to GlobalData, Pre-Registration drugs for Gastric Cancer have a 93% phase ...